US Patent 7759116 MVA virus vector expressing dengue NS1 protein
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+602 characters)
Article
Patent abstract
The present invention relates to NS1 proteins or parts thereof of Flaviviruses, in particular of Dengue viruses useful for vaccination against said Flavivirus and against one or more other Flaviviruses. The invention further concerns the NS1 protein or parts thereof of one Dengue virus serotype, in particular serotype 2, useful for vaccination against Dengue viruses from all serotypes. The invention further concerns DNA comprising an expression cassette coding for a Flavivirus NS1 or parts thereof, vectors comprising said DNA and vaccines containing or expressing a Flavivirus NS1.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Magdeline Sia Henry Sum0
Mary Jane Cardosa0
Paul Howley0
Sonja Leyrer0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07759116 MVA virus vector expressing dengue NS1 protein US Patent 7759116 MVA virus vector expressing dengue NS1 protein
Infobox
Patent Number
07759116
Patent Number
7759116
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07759116 MVA virus vector expressing dengue NS1 protein
Infobox
Is a
Patent jurisdiction
Patent number
07759116
Date of patent
July 20, 2010
Patent application number
10497633
Date Filed
June 3, 2004
Patent primary examiner
Find more entities like US Patent 7759116 MVA virus vector expressing dengue NS1 protein
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.